Gideon Capital Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-29,378
Closed -$2.02M 39
2019
Q4
$2.02M Buy
+29,378
New +$2M 0.7% 35
2019
Q3
Sell
-43,233
Closed -$3.1M 303
2019
Q2
$3.1M Buy
+43,233
New +$3.07M 1.07% 15
2019
Q1
Sell
-20,470
Closed -$1.22M 398
2018
Q4
$1.22M Sell
20,470
-512
-2% -$32K 0.5% 53
2018
Q3
$1.41M Sell
20,982
-21,743
-51% -$1.45M 0.66% 24
2018
Q2
$2.77M Buy
+42,725
New +$2.79M 1.38% 4
2016
Q3
Sell
-3,455
Closed -$253K 196
2016
Q2
$253K Buy
+3,455
New +$246K 0.15% 161
2015
Q3
Sell
-16,787
Closed -$1.1M 238
2015
Q2
$1.1M Buy
+16,787
New +$1.14M 0.45% 79
2015
Q1
Sell
-20,275
Closed -$1.4M 234
2014
Q4
$1.4M Sell
20,275
-440
-2% -$29.7K 0.66% 48
2014
Q3
$1.35M Buy
+20,715
New +$1.37M 0.52% 65

Other funds holding CL

Gideon Capital Advisors's CL Position: Q1 2020 in Review

Gideon Capital Advisors sold out of Colgate-Palmolive (CL) in Q1 2020, closing a stake of 29,378 shares — an estimated $2.02M sold.

Gideon Capital Advisors first reported a position in CL in Q3 2014 and held it in 9 quarters. The position peaked at $3.1M in Q2 2019. 1,494 funds tracked by Wall St. Rank hold CL as of Q1 2020.

  • Gideon Capital Advisors reported no remaining Colgate-Palmolive position as of Q1 2020 after selling out during the quarter.
  • Gideon Capital Advisors sold 29,378 Colgate-Palmolive shares in Q1 2020, an estimated $2.02M.
  • Gideon Capital Advisors first reported a position in Colgate-Palmolive in Q3 2014 and held it in 9 quarters.
  • Gideon Capital Advisors's Colgate-Palmolive position peaked at $3.1M in Q2 2019.
  • 1,494 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2020.

Based on Gideon Capital Advisors's 13F filing for Q1 2020.